These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7501395)
81. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia. Langeveld TP; Drost HA; Baatenburg de Jong RJ Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):280-4. PubMed ID: 9557760 [TBL] [Abstract][Full Text] [Related]
82. Does cognitive function influence alaryngeal speech rehabilitation? Ho TP; Gray J; Ratcliffe AA; Rees S; Rockey J; Wight RG Head Neck; 2006 May; 28(5):413-9. PubMed ID: 16287133 [TBL] [Abstract][Full Text] [Related]
83. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. Kraft SP; Lang AE CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771 [TBL] [Abstract][Full Text] [Related]
84. Multivariable analysis of risk factors for enlargement of the tracheoesophageal puncture after total laryngectomy. Hutcheson KA; Lewin JS; Sturgis EM; Risser J Head Neck; 2012 Apr; 34(4):557-67. PubMed ID: 21692129 [TBL] [Abstract][Full Text] [Related]
85. The management of advanced carcinoma of the tongue by total glossectomy without laryngectomy. Effron MZ Trans Pa Acad Ophthalmol Otolaryngol; 1981; 34(2):158-63. PubMed ID: 7314209 [No Abstract] [Full Text] [Related]
87. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm]. Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725 [TBL] [Abstract][Full Text] [Related]
88. Functional utility and oncologic safety of near-total laryngectomy with tracheopharyngeal speech shunt in a Third World oncologic center. Shenoy AM; Plinkert PK; Nanjundappa N; Premalata S; Arunodhay GR Eur Arch Otorhinolaryngol; 1997; 254(3):128-32. PubMed ID: 9112032 [TBL] [Abstract][Full Text] [Related]
89. Botulinum toxin treatment for spasmodic dysphonia. Kobayashi T; Niimi S; Kumada M; Kosaki H; Hirose H Acta Otolaryngol Suppl; 1993; 504():155-7. PubMed ID: 8470525 [TBL] [Abstract][Full Text] [Related]
90. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Carruthers J; Stubbs HA Can J Neurol Sci; 1987 Feb; 14(1):42-5. PubMed ID: 3815164 [TBL] [Abstract][Full Text] [Related]
91. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections. Price J; Farish S; Taylor H; O'Day J Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036 [TBL] [Abstract][Full Text] [Related]
92. Success and predictability of provox prosthesis voice rehabilitation. Hotz MA; Baumann A; Schaller I; Zbären P Arch Otolaryngol Head Neck Surg; 2002 Jun; 128(6):687-91. PubMed ID: 12049565 [TBL] [Abstract][Full Text] [Related]
93. Tracheoesophageal speech failure in the laryngectomee: the role of constrictor myotomy. Henley J; Souliere C Laryngoscope; 1986 Sep; 96(9 Pt 1):1016-20. PubMed ID: 3747687 [TBL] [Abstract][Full Text] [Related]
94. Treatment of facial spasm with Oculinum (C. botulinum toxin). Biglan AW; May M J Pediatr Ophthalmol Strabismus; 1986; 23(5):216-21. PubMed ID: 3772688 [TBL] [Abstract][Full Text] [Related]
95. [Voice rehabilitation with the jejunum speech siphon: the biventer rein, a modification for prevention of aspiration]. Remmert S; Ahrens KH; Sommer K; Müller G; Weerda H Laryngorhinootologie; 1994 Feb; 73(2):84-7. PubMed ID: 8161415 [TBL] [Abstract][Full Text] [Related]
96. [Treatment of hip adductor spasticity with botulinum toxin type B]. Oechsner M Nervenarzt; 2002 Dec; 73(12):1179-82. PubMed ID: 12486568 [TBL] [Abstract][Full Text] [Related]
97. Treatment of hemifacial spasm with botulinum toxin. Value of preinjection electromyography abnormalities for predicting postinjection lower facial paresis. Angibaud G; Moreau MS; Rascol O; Clanet M Eur Neurol; 1995; 35(1):43-5. PubMed ID: 7737246 [TBL] [Abstract][Full Text] [Related]